Skip to the page

Data / Form D filings / Auvi Labs, Inc.

Auvi Labs, Inc.: Form D filings

Auvi Labs, Inc., a biotechnology company in Chicago, IL, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on August 26, 2026, reports $442,352 sold of an offering with no set size to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1623 W Fulton St., Chicago, IL, 60612
Phone
(404) 663-1836
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2097988

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 26, 2026New noticeIndefinite$442,35211Jun 19, 2026sec.gov
Nov 25, 2025New notice$101,000$101,0002May 2, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rishab Rao VeldurExecutive Officer, Director
Eric HeinzDirector
Satyansh YeluriDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Aug 24, 2026 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Auvi Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.